United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
Go back to United Therapeutics Corporation Reports Second Quarter 2022 Financial Results| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 545.28 +6.98 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $538.30 | 52 Week High | $164.04 | |||
| Open | $542.08 | 52 Week Low | $97.52 | |||
| Day High | $545.48 | P/E | 99.69 | |||
| Day Low | $539.70 | EPS | $5.47 | |||
| Volume | 134,633 | |||||

